In 2023, GSK reported a total of 645,000 ton CO₂e, and a net revenue of 37,725 M USD, resulting in a emissions intensity of 17 t CO₂e / M USD.
Base year:
2020
Target year:
2030
Reduction:
0.8
Classification:
1.5°C
GSK commits to reduce absolute scope 1 and 2 GHG emissions 80% by 2030 from a 2020 base year.* *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks
Source: Science Based Target initative
Emissions, Revenue & Intensity
Emissions, Target & Trend
Emissions Overview | 2020 | 2021 | 2022 | 2023 |
Total Emissions - Market Based (t CO₂e) | 10,829,000 | 9,388,000 | 9,709,000 | 645,000 |
---|---|---|---|---|
Emissions Intensity (t CO₂e / M USD) | 346 | 276 | 268 | 17 |
Cradle-to-gate Intensity (t CO₂e / M USD) | 153 | 120 | 109 | 17 |